From BioHealth Investor
Biotechnology
PROGEN INDS LTD [PGLA] +119.66%
EXACT SCIENCES COR [EXAS] +12.89%
ANADYS PHARMACEUTICA [ANDS] +7.29%
ADVENTRX PHARMACTL [ANX] +6.36%
SGX PHARMACEUTICALS [SGXP] +5.71%
Diagnostic Substances
IMMUNOMEDICS INC [IMMU] +3.63%
SYNOVICS PHARMACEUTL [SYVC.OB] +3.23%
REMOTEMDX INC [RMDX.OB] +3.17%
IMMUCELL CP [ICCC] +3.14%
VALERA PHARMACEUTICA [VLRX] +2.92%
Drug Delivery
IOMED INC [IOX] +5.15%
NOVADEL PHARMA INC [NVD] +2.58%
NOVEN PHARMACEUTIC [NOVN] +1.98%
BIOVAIL CORP [BVF] +1.43%
COLUMBIA LABS INC [CBRX] +1.42%
Drug Manufacturers
ACCESS PHARMACEUTICL [ACCP.OB] +32.56%
SANTARUS, INC. [SNTS] +7.49%
DEPOMED INC [DEPO] +6.10%
NITROMED, INC. [NTMD] +5.41%
ACUSPHERE INC [ACUS] +4.26%
Medical Appliances & Equipment
SRI/SURGICAL EXPRE [STRC] +10.92%
SOMANETICS CORP [SMTS] +8.16%
ORTHOFIX INTL NV [OFIX] +4.69%
PHOTOMEDEX INC [PHMD] +4.59%
WRIGHT MEDICAL GRO [WMGI] +4.31%
Medical Instruments & Supplies
STRATEGIC DIAGNOST [SDIX] +5.68%
BIOMIMETIC THERAPEUT [BMTI] +4.70%
ANGIODYNAMICS INC [ANGO] +4.40%
CPC OF AMERICA INC [CPCF.OB] +4.30%
ENPATH MED INC [NPTH] +3.95%
Medical Laboratories & Research
SPHERIX INC [SPEX] +4.76%
BIO-IMAGING TECH [BITI] +2.32%
BIO-REFERENCE LAB [BRLI] +0.70%
ARRAY BIOPHARMA IN [ARRY] +0.46%
NATL DENTEX CP [NADX] +0.34%
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
